Alpha Cognition Net Income 2020-2024 | ACOG
Alpha Cognition net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Alpha Cognition Annual Net Income
(Millions of US $) |
| 2023 |
$-14 |
| 2022 |
$-12 |
| 2021 |
$-20 |
| 2020 |
$-6 |
| 2019 |
$-7 |
Alpha Cognition Quarterly Net Income
(Millions of US $) |
| 2024-06-30 |
$-2 |
| 2024-03-31 |
$-5 |
| 2023-12-31 |
$-6 |
| 2023-09-30 |
$-3 |
| 2023-06-30 |
$-3 |
| 2023-03-31 |
$-2 |
| 2022-12-31 |
$-4 |
| 2022-09-30 |
$-2 |
| 2022-06-30 |
$-3 |
| 2022-03-31 |
$-3 |
| 2021-12-31 |
$-3 |
| 2021-09-30 |
$-4 |
| 2021-06-30 |
$0 |
| 2021-03-31 |
$-12 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-1 |
| 2020-06-30 |
$-2 |
| 2020-03-31 |
$-1 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
